Characteristics of patients with AML
| . | CD34+ ≤ 7.16 × 106/kg (n = 613) . | CD34+ > 7.16 × 106/kg (n = 159) . | Total (n = 772) . | P . |
|---|---|---|---|---|
| Follow-up, mo | 32 (1-162) | 27 (1-168) | 31 (1-168) | |
| Age, y | 47 (18-75) | 47.5 (19-77) | 47 (18-77) | .35 |
| Interval from diagnosis to CR1, d | 41 (10-168) | 38 (17-132) | 40 (10-168) | .054 |
| White blood cell count at diagnosis, per mL | 13.6 (0.4-555) | 24.1 (0.8-273) | 15 (0.4-555) | .002 |
| Median time of transplantation, mo/y | 11/2002 | 06/2002 | 11/2002 | .008 |
| Duration of CR1 to transplantation, d | 118 (80-439) | 105 (80-386) | 115 (80-844) | < .001 |
| Cytogenetics | ||||
| Good | 83 (14%) | 19 (12%) | 102 (13%) | |
| Intermediate | 382 (62%) | 96 (60%) | 478 (62%) | |
| Poor | 20 (3%) | 8 (5%) | 28 (4%) | |
| NA/missing | 128 (21%) | 36 (23%) | 164 (21%) | .66 |
| Total body irradiation | 48 (8%) | 19 (12%) | 67 (9%) | .1 |
| . | CD34+ ≤ 7.16 × 106/kg (n = 613) . | CD34+ > 7.16 × 106/kg (n = 159) . | Total (n = 772) . | P . |
|---|---|---|---|---|
| Follow-up, mo | 32 (1-162) | 27 (1-168) | 31 (1-168) | |
| Age, y | 47 (18-75) | 47.5 (19-77) | 47 (18-77) | .35 |
| Interval from diagnosis to CR1, d | 41 (10-168) | 38 (17-132) | 40 (10-168) | .054 |
| White blood cell count at diagnosis, per mL | 13.6 (0.4-555) | 24.1 (0.8-273) | 15 (0.4-555) | .002 |
| Median time of transplantation, mo/y | 11/2002 | 06/2002 | 11/2002 | .008 |
| Duration of CR1 to transplantation, d | 118 (80-439) | 105 (80-386) | 115 (80-844) | < .001 |
| Cytogenetics | ||||
| Good | 83 (14%) | 19 (12%) | 102 (13%) | |
| Intermediate | 382 (62%) | 96 (60%) | 478 (62%) | |
| Poor | 20 (3%) | 8 (5%) | 28 (4%) | |
| NA/missing | 128 (21%) | 36 (23%) | 164 (21%) | .66 |
| Total body irradiation | 48 (8%) | 19 (12%) | 67 (9%) | .1 |
Description of patients with AML who received autografts of peripheral blood stem cells, according to the infused dose of CD34+ cells. Data are median (range) or frequency (%).
AML indicates acute myelocytic leukemia; CR1, first remission; and NA, not applicable.